Fundz

Gain Therapeutics Appoints Jeanette Weidner as Vice President of Finance

PUBLIC · GANXOct 28, 2026

Position

Principal

Company

Gain Therapeutics

Jeanette Weidner
BethesdaBiotechnologyHealth CareTherapeutics

Description

On October 22, 2026, Gain Therapeutics, Inc. appointed Jeanette Weidner as Vice President of Finance, effective October 28, 2026. Ms

Who to call at Gain Therapeutics, and when

A new leader at Gain Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Gain Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gain Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gain Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gain Therapeutics

Location

Bethesda, Maryland, United States

About

Gain Therapeutics, Inc. is a clinical-stage biotechnology company leading the discovery and development of next generation allosteric therapies. Gain's lead drug candidate GT-02287 for the treatment of Parkinson's disease and other neurodegenerative diseases is currently being evaluated in a Phase 1 clinical trial. With its Magellan drug discovery platform, Gain is transforming drug discovery by integrating Al, physics-based methods and supercomputing power to discover novel allosteric binding sites and potential first-in-class drug candidates from on-demand libraries with 50 billion compounds in less than 3 months.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gain Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jonas
Likely contact at this company
••••••••@••••••••

See Jonas's verified email →

Gianluca
Likely contact at this company
••••••••@••••••••

See Gianluca's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Gain Therapeutics's next move

Learn about Strategic plan

Gain Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.